|
J. Harold Helderman, MD
|
| |
|
 |
This group of talks is
accredited for up to 1.5 AMA PRA Category 1 credits™.
This group of talks has a single post-test, which must be completed along with an evaluation
form to obtain credit. |
|
Date of Web Release: April 15, 2006
Credit Eligible Through: April 30, 2007
AMA PRA Category 1 Credits™: 1.5
Target Audience: Practicing nephrologists and internists.
Method of participation:
Listen to the talk(s), read the PubMed abstracts of linked slides and references,
take the post-test, read the abstracts linked to in the post-test feedback section.
|
 |
This
official symposium was supported by a restricted educational grant from Roche Laboratories, Inc.
The educational objectives for this talk are presented
on the conference page. To view the objectives, click
here.
SPEAKER DISCLOSURE STATEMENT and OFF-LABEL USE: |
Dr. Helderman:
grants/research support: Bristol-Myers Squibb, Fujisawa, Hoffman La Roche, Novartis; board position: Tutogen.
No disclosed off-label use.
ASN ACCREDITATION AND DESIGNATION STATEMENTS: |
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The ASN designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that non-US licensed physicians who participate in this CME activity are eligible for AMA PRA category 1 credit.
Additional CME policy statements of the ASN, which is the accrediting
organization for this talk, are given in detail on the ASN
Renal Week Home Page, including Disclaimer and User
Instructions.
HDCN CE POLICY STATEMENTS: |
The CME policy statements of HDCN are listed on
this page. |
|